Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page
- Check4 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.3%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location in Ghent, Belgium, along with new resources related to Alpha-1 Antitrypsin Deficiency and chronic lung diseases. However, several previous entries, including specific location details and some related topics, have been removed.SummaryDifference6%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.